Summit Therapeutics, Inc. (SMMT)
13.04
-1.26
(-8.78%)
USD |
NASDAQ |
Jun 10, 16:00
12.96
-0.08
(-0.58%)
After-Hours: 20:00
Summit Therapeutics Market Cap : 10.12B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 11.09B |
| June 08, 2026 | 10.95B |
| June 05, 2026 | 11.46B |
| June 04, 2026 | 11.52B |
| June 03, 2026 | 11.69B |
| June 02, 2026 | 11.53B |
| June 01, 2026 | 12.19B |
| May 29, 2026 | 13.61B |
| May 28, 2026 | 13.51B |
| May 27, 2026 | 13.47B |
| May 26, 2026 | 13.19B |
| May 22, 2026 | 12.90B |
| May 21, 2026 | 13.56B |
| May 20, 2026 | 13.89B |
| May 19, 2026 | 12.30B |
| May 18, 2026 | 12.43B |
| May 15, 2026 | 13.09B |
| May 14, 2026 | 14.08B |
| May 13, 2026 | 14.58B |
| May 12, 2026 | 14.71B |
| May 11, 2026 | 14.48B |
| May 08, 2026 | 14.03B |
| May 07, 2026 | 13.31B |
| May 06, 2026 | 13.85B |
| May 05, 2026 | 13.61B |
| Date | Value |
|---|---|
| May 04, 2026 | 13.18B |
| May 01, 2026 | 12.51B |
| April 30, 2026 | 16.66B |
| April 29, 2026 | 16.17B |
| April 28, 2026 | 16.50B |
| April 27, 2026 | 17.17B |
| April 24, 2026 | 17.12B |
| April 23, 2026 | 17.27B |
| April 22, 2026 | 19.06B |
| April 21, 2026 | 20.45B |
| April 20, 2026 | 19.48B |
| April 17, 2026 | 19.50B |
| April 16, 2026 | 18.93B |
| April 15, 2026 | 16.38B |
| April 14, 2026 | 16.17B |
| April 13, 2026 | 15.53B |
| April 10, 2026 | 15.25B |
| April 09, 2026 | 14.97B |
| April 08, 2026 | 14.58B |
| April 07, 2026 | 14.90B |
| April 06, 2026 | 14.49B |
| April 02, 2026 | 15.03B |
| April 01, 2026 | 14.67B |
| March 31, 2026 | 14.70B |
| March 30, 2026 | 13.17B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 28.84B |
| Denali Therapeutics, Inc. | 3.274B |
| NovelStem International Corp. | 0.444M |
| Brainstorm Cell Therapeutics, Inc. | 8.386M |
| Kezar Life Sciences, Inc. | 53.76M |
Market Cap Related Metrics
| PEG Ratio | -0.0212 |
| Price to Book Value | 18.53 |
| Price | 13.04 |
| Earnings Yield | -12.30% |
| PEGY Ratio | -0.0212 |